Evaluation of Pharmaceutical Care in Depressed Outpatients
NCT01571973 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2012-04-05
Summary
The study examines whether pharmacotherapeutic follow-up improves outcomes of treatment of depressed outpatients.
Conditions
Interventions
- PROCEDURE
-
pharmacotherapeutic follow-up
health education adjustment of dose improve compliance replacement of medication
Sponsors & Collaborators
-
Federal University of São Paulo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2012-03-31
- Completion
- 2012-05-31
More Related Trials
-
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
NCT00375973 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Duloxetine for Perimenopausal Depression
NCT00517985 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine for Menopausal Depression
NCT01117857 ·Status: COMPLETED ·Phase: PHASE4
-
Fluoxetine Treatment of Depression in Down Syndrome
NCT05458479 ·Status: COMPLETED ·Phase: PHASE4
-
6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder
NCT01145755 ·Status: TERMINATED ·Phase: PHASE2
-
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain
NCT00191919 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder
NCT01977378 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects
NCT00933452 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder
NCT01254305 ·Status: COMPLETED ·Phase: PHASE2
-
Duloxetine Versus Paroxetine for Major Depression
NCT00489775 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
NCT05792540 ·Status: COMPLETED ·Phase: PHASE2
-
Switching to Duloxetine From Other Antidepressants
NCT00191932 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
NCT00191061 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
NCT00042562 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain
NCT02232555 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
NCT07300969 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression
NCT02229825 ·Status: COMPLETED ·Phase: PHASE4
-
Switching to Duloxetine in Patients With Depression
NCT00696774 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
NCT01808612 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects
NCT01531972 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Cognitive Functioning Before and After Treatment With Duloxetine
NCT00933439 ·Status: COMPLETED ·Phase: NA
-
A Study of MD-120 in Patients With Depression
NCT04345471 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
NCT00073411 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial
NCT03121573 ·Status: COMPLETED ·Phase: NA
-
Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
NCT00071695 ·Status: COMPLETED ·Phase: PHASE4